Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bruker (BRKRP) Invested Capital (2016 - 2025)

Historic Invested Capital for Bruker (BRKRP) over the last 17 years, with Q3 2025 value amounting to $2.5 billion.

  • Bruker's Invested Capital rose 3315.03% to $2.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 billion, marking a year-over-year increase of 3315.03%. This contributed to the annual value of $1.8 billion for FY2024, which is 2070.19% up from last year.
  • As of Q3 2025, Bruker's Invested Capital stood at $2.5 billion, which was up 3315.03% from $1.9 billion recorded in Q2 2025.
  • In the past 5 years, Bruker's Invested Capital registered a high of $2.5 billion during Q3 2025, and its lowest value of $965.0 million during Q3 2022.
  • In the last 5 years, Bruker's Invested Capital had a median value of $1.8 billion in 2021 and averaged $1.6 billion.
  • As far as peak fluctuations go, Bruker's Invested Capital crashed by 5268.73% in 2022, and later skyrocketed by 3969.95% in 2023.
  • Quarter analysis of 5 years shows Bruker's Invested Capital stood at $2.4 billion in 2021, then crashed by 52.69% to $1.1 billion in 2022, then skyrocketed by 32.45% to $1.5 billion in 2023, then grew by 20.7% to $1.8 billion in 2024, then surged by 35.21% to $2.5 billion in 2025.
  • Its Invested Capital stands at $2.5 billion for Q3 2025, versus $1.9 billion for Q2 2025 and $1.9 billion for Q1 2025.